Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis

Figure 2 Meta-analysis. A: Hepatitis B virus (HBV) DNA undetectability in the two treatment groups; B: HBV DNA levels in the two treatment groups; C: Hepatitis B e antigen (HBeAg) seroconversion in the two treatment groups; D: Alanine aminotransferase (ALT) levels in the two treatment groups; E: Albumin (ALB) levels in the two treatment groups; F: Total bilirubin (TBIL) levels in the two treatment groups; G: The child-Turcotte-Pugh (CTP) score in the two treatment groups; H: Prothrombin time activity (PTA) levels in the two treatment groups; I: Drug-resistance in the two treatment groups; J: Mortality in the two treatment groups; K: The two treatment groups included in the Randomized controlled trials (RCTs). ETV: Entecavir; LAM: Lamivudine.